Evaxion Biotech A/S banner

Evaxion Biotech A/S
NASDAQ:EVAX

Watchlist Manager
Evaxion Biotech A/S Logo
Evaxion Biotech A/S
NASDAQ:EVAX
Watchlist
Price: 2.83 USD -0.35% Market Closed
Market Cap: $23.6m

Wall St Price Targets

EVAX Price Targets Summary
Evaxion Biotech A/S

Wall Street analysts forecast EVAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.

Lowest Forecast
Price Target
9.09 USD
221% Upside
Average Forecast
Price Target
11.48 USD
305% Upside
Highest Forecast
Price Target
16.8 USD
494% Upside
Evaxion Biotech A/S Competitors:
Price Targets
QNST
Quinstreet Inc
25% Upside
SANA
Sana Biotechnology Inc
178% Upside

Revenue
Forecast

N/A
Past Growth
62% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
62% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 8 years is 62%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EVAX's stock price target?
Price Target
11.48 USD

According to Wall Street analysts, the average 1-year price target for EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.

What is the Revenue forecast for Evaxion Biotech A/S?
Projected CAGR
62%

The compound annual growth rate for Revenue over the next 8 years is 62%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett